BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 28193525)

  • 1. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway.
    Yang N; Dang S; Shi J; Wu F; Li M; Zhang X; Li Y; Jia X; Zhai S
    Biochem Biophys Res Commun; 2017 Apr; 486(1):22-28. PubMed ID: 28193525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
    Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
    Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway.
    Liu X; Zhao X
    Biomed Pharmacother; 2017 Sep; 93():57-61. PubMed ID: 28623783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
    Yang Y; Kim B; Park YK; Koo SI; Lee JY
    Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid phenethyl ester inhibits liver fibrosis in rats.
    Li M; Wang XF; Shi JJ; Li YP; Yang N; Zhai S; Dang SS
    World J Gastroenterol; 2015 Apr; 21(13):3893-903. PubMed ID: 25852274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
    Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
    Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice.
    Fan K; Wu K; Lin L; Ge P; Dai J; He X; Hu K; Zhang L
    Biomed Pharmacother; 2017 Jun; 90():421-426. PubMed ID: 28390311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
    Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
    PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
    França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
    Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
    Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
    Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways.
    Shi L; Zhou L; Han M; Zhang Y; Zhang Y; Yuan XX; Lu HP; Wang Y; Yang XL; Liu C; Wang J; Liang P; Liu SA; Liu XJ; Cheng J; Lin SM
    World J Gastroenterol; 2023 May; 29(18):2798-2817. PubMed ID: 37274069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.